| Maintenance electroconvulsive therapy for Parkinson's disease. | |
| | |
MedLine Citation:
|
PMID: 9437571 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In two patients with severe Parkinson's disease (PD) whose response to levodopa had decreased, the parkinsonian motor symptoms responded to acute and maintenance unilateral electroconvulsive therapy (ECT). Case 1 relapsed while taking antiparkinsonian medication 2 and 3 months after two brief courses of ECT. After another relapse, he received maintenance ECT and stayed well for 13 months. Case 2 relapsed 4 months after a course of ECT. Acute and maintenance ECT induced improvement for 14 months. Further relapses were treated with brief courses of ECT followed by maintenance ECT. Three and 4 years after their first ECT, the parkinsonian motor symptoms in these two patients are still markedly improved. Neuropsychological assessments did not suggest ECT-induced long-term cognitive impairment. We conclude that maintenance ECT should be considered in PD patients who relapse after having responded to an initial course of ECT. There is an urgent need for controlled studies. |
| | |
Authors:
|
D Aarsland; J P Larsen; O Waage; J H Langeveld |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Convulsive therapy Volume: 13 ISSN: 0749-8055 ISO Abbreviation: Convuls Ther Publication Date: 1997 Dec |
Date Detail:
|
Created Date: 1998-03-05 Completed Date: 1998-03-05 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8506311 Medline TA: Convuls Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 274-7 Citation Subset: IM |
Affiliation:
|
Section of Geriatric Psychiatry, Psychiatric Hospital of Rogland, Stavanger, Norway. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antiparkinson Agents / therapeutic use Electroconvulsive Therapy* / adverse effects Female Fluvoxamine / therapeutic use Functional Laterality Humans Informed Consent Levodopa / therapeutic use Male Parkinson Disease / psychology, therapy* Serotonin Uptake Inhibitors / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Antiparkinson Agents; 0/Levodopa; 0/Serotonin Uptake Inhibitors; 54739-18-3/Fluvoxamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Quantifying utilization and practice variation of electroconvulsive therapy.
Next Document: Effect of exogenous estradiol on plasma concentrations of somatotropin, insulin-like growth factor-I...